Global Topical Dispenser Market was evaluated at USD 418 billion in 2019 and is
anticipated to reach USD 631.8 billion by 2027, at a CAGR of 5.3 % during the
projection period. The primary reason
triggering the development of topical applicators is the need to eliminate
human contact for minimizing or negating any transmission. Besides, the topical
applicators facilitate the precision of the amount in drug administration.
Topical applicators are widely used in dermal therapies and dermatological
treatment, especially for psoriasis. A large number of medicines related to
skin are topical and require topical applicators for safe application.
Development in the therapeutic industry in countries like China and India is
pitched to push demand for topical applicators during the projection period.
Global Topical Dispenser
Market – Overview
Topical applicators are
used for dispensing peels or skin protectants, ointments, gels, creams, masks,
disinfectants, and drugs. As topical medications are on the rise, the request
for topical applicators is anticipated to surge. Metered topical applicators
guarantee the precise quantity of balm or other ointments on the body surface.
The thematic device dispenses the specified amount of medication in a
user-friendly manner with just one click. Topical applicators are reliable as
they offer automatic and consistent dose that reduces user-variability and
assures viscosity. Topical applicators do not allow an excess of the medication
by maintaining uniform mixing and filling of the medicinal product.
Increasing prevalence of
psoriasis and a rising aging population with skin diseases
Psoriasis is a prolonged,
sore, and non-communicable skin disease. It is most common in the geriatric
population with age group 50 - 69. As per the National Psoriasis Foundation
Report 2018, around 125 million people have psoriasis worldwide. The prevalence
of psoriasis has amplified the demand for topical dispensers in the industry.
Skin disease is a significant healthcare problem accounting for 1.79% of the
global burden of diseases in DALYs of 306 diseases and injuries. As per the
WHO, approximately 900 million individuals were suffering from skin ailments
globally in 2018. This scenario is eventually growing the demand for the
topical dispenser, strengthening its market.
Easy use of Topical
The precise and easy
administration of medication with the topical applicators is the primary factor
leading the global topical applicators market during the forthcoming period.
Higher demand is being witnessed from the skincare sector, particularly for
psoriasis and other skin therapies. A large number of medications concerning
skin are topical and need topical applicators for safe use. Metered topical
applicators safeguard the application of the right quantity of ointment on the
body external. They are dependable devices for the automated and accurate dose,
reducing variability, and delivering uniform viscosity.
Global Topical Dispenser
Based on the product, the
market is divided into semi-solid formulations (creams, pastes, gels,
ointments, and lotions), liquid formulations (solutions and suspensions), solid
formulations (suppositories and powders) and transdermal products (transdermal
patches and transdermal semi-solids). The semi-solid formulations section is
anticipated to account for the significant market share of the market in 2019.
They offer advantages of faster drug release and better acceptability of
topical gels by the patient. Extensive use of topical pastes to avoid skin
irritation, infectiousness, and the possibility of quick removal of creams for
curing various ailments related to different skin types is the dominant element
stimulating this market's growth.
The dermal drug delivery
segment accounted for the largest share of the market in 2018. It is mainly due
to the high occurrence of skin ailments across the globe. For instance, the
occurrence of psoriasis universal series between 0.09% and 11.43% has become a
severe problem worldwide with at least 100 million individuals affected
worldwide. (Source: WHO 2016).
accounted for the significant share of the market in 2018 in terms of facility
of use. Home care settings eliminate the need for patients to travel to
healthcare facilities, thus saving time and money. Owing to its convenience and
affordability, a growing number of patients are opting for home-based cures.
These factors reassure the growth of this market segment.
Based on region, Global
Topical Dispenser Market is segregated by crucial regions— North America,
Europe, Asia Pacific, South America, and the Middle East & Africa.
Global Topical Dispenser
Market: Regional Insights
North America dominated
the Topical dispenser market in 2019, and it is pitched to notice the highest
CAGR during the prediction period. The widespread skin diseases, rising approvals
and launches of innovative topical formulations in the region, and growing funding
for topical drugs' development are some of the key elements propelling the
growth of this regional segment. The growing pharmaceutical industry in
countries like China and India is anticipated to drive the market for topical
applicators during the projected period. Europe is more evolved as topical
applicators market compared to other regions such as Asia and MEA. The GCC
countries and North Africa are anticipated to witness a medium to high growth
in the topical applicators market during this period.
The prominent players in the market are Johnson & Johnson (US),
Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK),
Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany),
Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd
(India), Crescita Therapeutics Inc. (Canada), and Mylan (US) and others.
Ø In December 2018, Cipher Pharmaceuticals Inc. (Canada) received
acceptance for its “A-101 40% topical solution” for the Health Canada review.
This product is prescribed to treat advanced seborrheic keratosis, a commonly
occurring non-cancerous skin growth that affects more than 9 million Canadian
Ø In December 2018, GlaxoSmithKline (UK) invested USD 36.0 million
in manufacturing facilities in Canada to produce and distribute its best
topical pain reliever—VOLTAREN.
Scope of the Report
data – 2016-2019
Base Year –
2020 – 2026
Revenue in USD Million
U.S, Canada, Germany, UK,
France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South
Korea UAE, South Africa, Saudi Arabia.
By Product formulations, By Route of Administration, By Facility of use
& Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland),
GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US),
Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark
Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc.
(Canada), and Mylan (US).
Ø Semi-solid Formulations
Ø Liquid Formulations
Ø Solid Formulations
Ø Transdermal Products
ü Transdermal Patches
ü Transdermal Semi-solids
By Route of Administration
Ø Dermal Drug Delivery
Ø Ophthalmic Drug Delivery
Ø Rectal Drug Delivery
Ø Vaginal Drug Delivery
Ø Nasal Drug Delivery
By Facility of use
Ø Homecare Settings
Ø Hospitals & Clinics
Ø Burn Centers
Ø Other Facilities (academic & research institutes and
Ø North America
Ø Asia Pacific
Ø Latin America
Ø Middle East & Africa
The objective of the Study:
Ø To analyze and project the Global Topical Dispenser Market size
in terms of value.
Ø To examine the region-wise segmentation of the Global Topical
Dispenser market and assess the market size in terms of value for each region
viz., North America, Europe, Asia Pacific, Middle East & Africa, Latin
America, and their leading countries.
Ø To outline, segregate, and estimate the Global Topical Dispenser
Market based on different classifications, i.e., By Product formulations, By
Route of Administration, By Facility of use, and By Region.
Ø To scrutinize category-wise competitive developments in the
Global Topical Dispenser Market based on Water Storage Tank Type, its
Application, and Region.
Ø To interpret the current market dynamics, by analyzing growth
drivers, restraints, opportunities, and challenges and their impact.
Ø To provide a detailed competitive landscape, including major
players, strategic profiles, and market shares.
Business Questions Answered by the Report
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis